LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.31623
47.93 27.76 824 4421 0.1864 0.5896
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
47.93 27.76 67 4421 0.0152 0.1280
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
47.93 27.76 1052 4421 0.2379 0.6436
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
49.63 27.76 77 4818 0.0160 0.1470
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
49.63 27.76 890 4818 0.1847 0.5938
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
49.63 27.76 78 4818 0.0162 0.1490
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
49.63 27.76 1096 4818 0.2275 0.6390
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
51.33 27.76 70 5117 0.0137 0.1308
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
51.33 27.76 889 5117 0.1737 0.5850
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
51.33 27.76 79 5117 0.0154 0.1491
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
51.33 27.76 1063 5117 0.2077 0.6231
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
53.04 27.76 79 5365 0.0147 0.1477
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
53.04 27.76 900 5365 0.1677 0.5810
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
53.04 27.76 80 5365 0.0149 0.1496
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
53.04 27.76 1039 5365 0.1936 0.6112
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
54.74 27.76 83 5606 0.0148 0.1538
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
54.74 27.76 893 5606 0.1593 0.5734
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
54.74 27.76 85 5606 0.0152 0.1574
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
54.74 27.76 1028 5606 0.1834 0.6026
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
56.45 27.76 88 5745 0.0153 0.1618
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
56.45 27.76 861 5745 0.1499 0.5627
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
56.45 27.76 68 5745 0.0118 0.1235
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
56.45 27.76 1062 5745 0.1848 0.6059
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
58.15 27.76 96 5906 0.0163 0.1740
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
58.15 27.76 877 5906 0.1485 0.5629
MN20160318_Q01
H15